This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Myriam Gorospe: Innovator in Sensotherapeutics
Introduction
Myriam Gorospe is a distinguished inventor based in Elliot City, MD (US). She has made significant contributions to the field of sensotherapeutics, focusing on innovative solutions for age-related diseases and disorders. Her work is characterized by a commitment to improving health outcomes through scientific advancements.
Latest Patents
Myriam Gorospe holds a patent for "Gingerenone A prodrugs as sensotherapeutics and methods of use." This patent describes Gingerenone A prodrug compounds that possess a specific structure, which can be utilized for inhibiting or eliminating senescence. The compounds are particularly useful for individuals suffering from senescence-associated diseases, neuroinflammation, pain, and amino acid deficiencies. She has 1 patent to her name, showcasing her innovative approach to addressing complex health issues.
Career Highlights
Gorospe's career is marked by her role at the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this capacity has allowed her to contribute to significant health initiatives and research projects aimed at enhancing public health.
Collaborations
Throughout her career, Myriam Gorospe has collaborated with notable colleagues, including Ruin Moaddel and Luigi Ferrucci. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Myriam Gorospe's innovative work in the field of sensotherapeutics highlights her dedication to improving health outcomes through scientific research. Her contributions, particularly in the development of Gingerenone A prodrugs, demonstrate her commitment to addressing age-related health challenges.